CS274627B2 - Method of oxetanocine derivative preparation - Google Patents
Method of oxetanocine derivative preparationInfo
- Publication number
- CS274627B2 CS274627B2 CS340888A CS340888A CS274627B2 CS 274627 B2 CS274627 B2 CS 274627B2 CS 340888 A CS340888 A CS 340888A CS 340888 A CS340888 A CS 340888A CS 274627 B2 CS274627 B2 CS 274627B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- oxetanocine
- derivative
- derivative preparation
- preparation
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 abstract 1
- 102000055025 Adenosine deaminases Human genes 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- LMJVXGOFWKVXAW-OXOINMOOSA-N oxetanocin A Chemical class C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@H]1CO LMJVXGOFWKVXAW-OXOINMOOSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
The method of preparation of oxetanocin derivative of formula I consists in the fact that the derivative of formula II is let to react with adenosine deaminase in presence of water or water solvent at a temperature of 10 to 40 degrees C. The compound of formula I, as well as its physiologically acceptable salts, shows primarily immunosuppressive and antiviral effects.<IMAGE>
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS59588A CS274890B2 (en) | 1987-05-19 | 1988-05-19 | Method of oxetanocine derivative preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12015987 | 1987-05-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CS340888A2 CS340888A2 (en) | 1990-12-13 |
CS274627B2 true CS274627B2 (en) | 1991-09-15 |
Family
ID=14779414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS340888A CS274627B2 (en) | 1987-05-19 | 1988-05-19 | Method of oxetanocine derivative preparation |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPH01100192A (en) |
CS (1) | CS274627B2 (en) |
-
1988
- 1988-05-18 JP JP63119153A patent/JPH01100192A/en active Granted
- 1988-05-19 CS CS340888A patent/CS274627B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0565520B2 (en) | 1993-09-17 |
CS340888A2 (en) | 1990-12-13 |
JPH01100192A (en) | 1989-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3026225T3 (en) | Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents | |
JPS57144298A (en) | 7-beta-d-arabinofuranosyl-7h- pyrrolo(2,3-d)pyrimidine compound and manufacture | |
ES2008256A6 (en) | Cosmetic sunscreen product for the face and body | |
DE3173954D1 (en) | Use of adenosin derivatives for the manufacture of psychopharmacons | |
DK0598770T3 (en) | Pyrazine derivatives and their preparation and use | |
AU5300979A (en) | Derivatives obtained by condensing 6-(5-cholesten-3beta- yloxy) hexyl compound with hexoses | |
DE3268816D1 (en) | Sulfur-substituted phenoxypyridines having antiviral activity | |
JPS5746999A (en) | Beta-d-arabinofuranosylimidazo(4,5-c)pyridine compound and manufacture | |
ZA865737B (en) | O-sulfate derivatives of avermectins and milbemycins having improved water solubility | |
CS274627B2 (en) | Method of oxetanocine derivative preparation | |
JPS56102794A (en) | Preparation of pyrimidine ribonucleosides and pyrimidine deoxyribonucleosides | |
JPS5227783A (en) | Preparation of unsaturated nucleosides | |
CS274890B2 (en) | Method of oxetanocine derivative preparation | |
JPS5356690A (en) | Purin compund sugar derivatives and their preparation | |
FI900098L (en) | Process for the preparation of 5H-pyrido/1',2':4,5/thiadiazino/2,3-a/benzimidazolium derivatives useful as pharmaceuticals | |
NZ233646A (en) | Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions | |
JPS5424862A (en) | Norbornane and norbornene derivatives | |
JPS55100399A (en) | Preparation of purine nucleoside-5'-monophosphate | |
JPS5344591A (en) | Preparation of adenine derivatives | |
JPS5386094A (en) | Preparation of 7-amino-cephem derivatives | |
JPS53124293A (en) | Novel adenosine derivatives | |
RU1807052C (en) | 1,10-phenantrolinates of sodium or potassium 4-nitrophenyl-pyridinyl methanides having indicating properties to water or protonic organic solvents with interval of transition from blue to colorless at pk of 29 | |
JPS53127834A (en) | Anti-tumor preparation | |
JPS53137974A (en) | Preparation of 5-fluorouracil derivatives | |
JPS5432494A (en) | Novel cycloimidazoline riboside derivatives and their preparation |